AI assistant
Permanent TSB Group Holding — Director's Dealing 2024
Mar 7, 2024
1971_dirs_2024-03-07_247c0aaf-4839-4c51-a668-94129a8990a2.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 0304G
Permanent TSB Group Holdings PLC
07 March 2024
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Julie O'Neill
2
Reason for the notification
a)
Position/status
Board Chairperson
b)
Initial Notification Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Permanent TSB Group Holdings plc
b)
LEI
635400DTNHVYGZODKQ93
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument,
type of
instrument
Identification code
Permanent TSB Group Holdings plc Ordinary €0.50 Shares
IE00BWB8X525
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| €1.61 | 10,000 |
d)
Aggregated information
- Aggregated volume
- Price
Not applicable - single transaction
e)
Date of the transaction
7 March 2024
f)
Place of the transaction
Dublin , Ireland
g)
Additional Information
Following the transaction disclosed here, Julie O'Neill beneficially owns 20,000 ordinary shares of €0.50 each in Permanent TSB Group Holdings plc.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHLDLFBZXLXBBE